Keywords: Johnson & Johnson, Pfizer, Legal costs, Risperdal, Prempro, M&A, Teva, Taiyo

Johnson & Johnson and Pfizer prepare for massive legal costs; Teva confirms Taiyo buy

Article | 16 May 2011

Print This

According to press reports emerging ahead of the weekend, two US drug giants, Pfizer (NYSE: PFE) and Johnsons & Johnson ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in